In the study by Hackam et al., it was found that when TLR4 was activated; it could activate the NF-κB inflammatory pathway, trigger a series of inflammatory responses, promote inflammation in vivo, and trigger intestinal barrier failure, thereby aggravating NEC symptoms [31]. The gene discussed is TLR4; the disease is necrotizing enterocolitis.